Daunorubicin (Daunomycin) hydrochloride 是一種拓撲異構酶 II (topoisomerase II) 抑制劑，具有有效的抗腫瘤活性。Daunorubicin hydrochloride 抑制 DNA 和 RNA 合成 (DNA and RNA synthesis)。Daunorubicin hydrochloride 是一種細胞毒素，可抑制癌細胞活力并誘導細胞凋亡 (apoptosis) 和壞死 (necrosis)。Daunorubicin hydrochloride 還是一種蒽環(huán)類抗生素。Daunorubicin hydrochloride 可用于研究感染和多種癌癥，包括白血病、非霍奇金淋巴瘤、尤文氏肉瘤、維爾姆斯氏瘤。

Daunorubicin hydrochloride (0-256 μg/mL, 30 min) inhibits DNA and RNA synthesis in sensitive and resistant Ehrlich ascites tumor cells[2].
Daunorubicin hydrochloride (7 nM-1.9 μM, 72 h) shows chemosensitivity in Molt-4 cells and L3.6 cells[3][4].
Daunorubicin hydrochloride (0.4 μM, 48 h) induces apoptotic and necrosis in L3.6 cells[4].
Daunorubicin hydrochloride (0.4 μM, 120 min) induces ROS generation in L3.6 cells[4].
Daunorubicin hydrochloride (2 μM, 24 h) induces autophagy in K562 cells (myeloid cell line)[6].

Daunorubicin hydrochloride (intravenous injection, 3 mg/kg, three times at 48 h intervals.) produces cardiotoxicity and nephrotoxicity in rats[5].
Daunorubicin hydrochloride (intraperitoneal injection, 10 mg/kg) induces sister chromatid exchanges in mice[7].